As of Sep 30, 2024, Fresenius Medical Care AG & Co. KGaA's fair value using the Ben Graham formula is ($27.6) per share. This is calculated using Ben Graham formula, where EPS is €1.5 and BVPS (Book Value Per Share) is €50.4. The current price of $22.9 suggests Fresenius Medical Care AG & Co. KGaA may be overvalued by this conservative metric.
Fresenius Medical Care AG & Co. KGaA earnings per share (EPS) for the twelve months ending Sep 30, 2024, was €1.5, a (13.7%) growth year-over-year.
Fresenius Medical Care AG & Co. KGaA's margin of safety is negative 220.2%, calculated as (Graham Number - Current Price) / Current Price. A negative margin of safety suggests the stock doesn't provide the level of safety Graham typically sought in his investments.